Additionally, we targeted CASP1 and CASP5 using CRISPR-Cas9 delivery via lipid nanoparticles (LNPs) to selectively knock out these genes in keratinocytes, resulting in significant therapeutic effects in the IMQ-induced psoriasis mouse model. This evidence concerns the gene CASP1 and psoriasis.